Bovie Medical Corp. (BVX)

3.80
AMEX : Health Technology
Prev Close 3.81
Day Low/High 3.73 / 3.88
52 Wk Low/High 2.17 / 4.29
Avg Volume 90.20K
Exchange AMEX
Shares Outstanding 32.88M
Market Cap 125.27M
EPS -0.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Bovie Medical Corporation Reports First Quarter 2018 Financial Results; Reaffirms Fiscal Year 2018 Financial Outlook

Bovie Medical Corporation Reports First Quarter 2018 Financial Results; Reaffirms Fiscal Year 2018 Financial Outlook

Bovie Medical Corporation (NYSEMKT:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma ®, a patented surgical product marketed and sold under the Renuvion™ Cosmetic Technology brand in the cosmetic surgery market,...

Bovie Medical Corporation Announces Completion Of Enrollment In J-Plasma®/RenuvionTM Dermal Resurfacing Study

Bovie Medical Corporation Announces Completion Of Enrollment In J-Plasma®/RenuvionTM Dermal Resurfacing Study

Bovie Medical Corporation (NYSEMKT:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma ®, a patented surgical product marketed and sold under the Renuvion™ Cosmetic Technology brand in the cosmetic surgery market,...

Bovie Medical Corporation Announces Appointment Of Diane I. Duncan, M.D., FACS To Medical Advisory Board

Bovie Medical Corporation Announces Appointment Of Diane I. Duncan, M.D., FACS To Medical Advisory Board

Bovie Medical Corporation (NYSEMKT:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma®, a patented surgical product marketed and sold under the Renuvion™ Cosmetic Technology brand in the cosmetic surgery...

Bovie Medical Corporation To Release First Quarter Of Fiscal Year 2018 Financial Results On May 14, 2018

Bovie Medical Corporation To Release First Quarter Of Fiscal Year 2018 Financial Results On May 14, 2018

Bovie Medical (NYSE: BVX), a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, today announced that financial results for the first quarter of fiscal year 2018 will be released after the...

Bovie Medical Corporation Announces Launch Of Renuvion™: A New Brand Dedicated To The Cosmetic Surgery Market

Bovie Medical Corporation Announces Launch Of Renuvion™: A New Brand Dedicated To The Cosmetic Surgery Market

Bovie Medical Corporation (NYSEMKT:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma ®, a patented surgical product, today announced the launch of Renuvion™, a new brand...

Bovie Medical Corporation Announces Appointment Of Scott R. Sanders As Director Of Clinical Education And Market Development

Bovie Medical Corporation Announces Appointment Of Scott R. Sanders As Director Of Clinical Education And Market Development

Bovie Medical Corporation (NYSEMKT:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma ®, a patented surgical product, today announced the appointment of Scott R.

Bovie Medical Corporation Reports Fourth Quarter And Full Year 2017 Financial Results; Provides Fiscal Year 2018 Financial Outlook

Bovie Medical Corporation Reports Fourth Quarter And Full Year 2017 Financial Results; Provides Fiscal Year 2018 Financial Outlook

Bovie Medical Corporation (NYSEMKT:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma ®, a patented surgical product, today reported financial results for its fourth quarter...

Bovie Medical Corporation Announces Appointment Of Craig A. Swandal To Board Of Directors

Bovie Medical Corporation Announces Appointment Of Craig A. Swandal To Board Of Directors

Bovie Medical Corporation (NYSEMKT:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma ®, a patented surgical product, today announced the appointment of Craig A.

Bovie Medical Corporation Announces Appointment Of Dr. Topaz J. Kirlew As Director Of Regulatory Affairs

Bovie Medical Corporation Announces Appointment Of Dr. Topaz J. Kirlew As Director Of Regulatory Affairs

Bovie Medical Corporation (NYSEMKT:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma ®, a patented new surgical product, today announced the appointment of Dr.

Bovie Medical Corporation To Release Fourth Quarter And Fiscal Year 2017 Financial Results On March 12, 2018

Bovie Medical Corporation To Release Fourth Quarter And Fiscal Year 2017 Financial Results On March 12, 2018

Bovie Medical (NYSEAM: BVX), a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, today announced that financial results for the fourth quarter and fiscal year...

Bovie Medical Corporation Announces Enrollment Of First Patient In J-Plasma® Dermal Resurfacing Clinical Study

Bovie Medical Corporation Announces Enrollment Of First Patient In J-Plasma® Dermal Resurfacing Clinical Study

Bovie Medical Corporation (NYSEMKT:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma ®, a patented new surgical product, today announced that it has enrolled the first patient...

Bovie Medical Corporation Appoints Charles D. Goodwin Chief Executive Officer; Updates 2017 Outlook

Bovie Medical Corporation Appoints Charles D. Goodwin Chief Executive Officer; Updates 2017 Outlook

Bovie Medical Corporation (NYSEMKT:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma ®, a patented new surgical product, today announced that Charles D.

Bovie Medical Corporation To Participate In Upcoming Investor Conferences

Bovie Medical Corporation To Participate In Upcoming Investor Conferences

Bovie Medical Corporation (BVX), a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, today announced that management will participate in the following investor...

Bovie Medical Corporation Reports Third Quarter 2017 Financial Results And Updates Fiscal Year 2017 Financial Outlook

Bovie Medical Corporation Reports Third Quarter 2017 Financial Results And Updates Fiscal Year 2017 Financial Outlook

Bovie Medical Corporation (NYSEMKT:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma ®, a patented new surgical product, today reported financial results for its third fiscal...

Bovie Medical Corporation To Release Third Quarter 2017 Financial Results On November 2, 2017

Bovie Medical Corporation To Release Third Quarter 2017 Financial Results On November 2, 2017

Bovie Medical (NYSE American: BVX), a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, today announced that financial results for the third quarter of...

Bovie Medical Corporation To Present At The Wedbush PacGrow Healthcare Conference

Bovie Medical Corporation To Present At The Wedbush PacGrow Healthcare Conference

Bovie Medical Corporation (BVX), a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, today announced that management will participate in the Wedbush PacGrow...

Bovie Medical Corporation Reports Second Quarter 2017 Financial Results And Reaffirms Fiscal Year 2017 Financial Outlook

Bovie Medical Corporation Reports Second Quarter 2017 Financial Results And Reaffirms Fiscal Year 2017 Financial Outlook

Bovie Medical Corporation (NYSEMKT:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma ®, a patented new surgical product, today reported financial results for its second fiscal...

Bovie Medical Corporation To Release Second Quarter 2017 Financial Results On August 2, 2017

Bovie Medical Corporation To Release Second Quarter 2017 Financial Results On August 2, 2017

Bovie Medical (BVX), a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, today announced that financial results for the second quarter of 2017 will be released...

Bovie Medical Corporation To Present At The JMP Securities Life Sciences Conference

Bovie Medical Corporation (NYSEMKT:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, today announced that management will participate in the...

Bovie Medical Corporation Reports First Quarter 2017 Financial Results And Introduces Fiscal Year 2017 Financial Outlook

Bovie Medical Corporation (NYSEMKT:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma ®, a patented new surgical product, today reported financial results for its first fiscal...

Bovie Medical Receives 510K Clearance For Its J-Plasma® Precise Flex Handpiece

Bovie Medical (NYSE MKT:BVX) announced today that it has received 510K clearance from the FDA for a new J-Plasma® Precise Flex handpiece.

Bovie Medical Corporation To Release First Quarter 2017 Financial Results On May 15, 2017

Bovie Medical (NYSE MKT: BVX), a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, today announced that financial results for the first quarter of 2017 will...

Bovie Medical Receives 510K Clearance For Its Cool-Coag™ Generator And Open Handpiece

Bovie Medical (NYSE:BVX) announced today that it has received 510K clearance from the FDA for a new J-Plasma® generator and handpiece that incorporate Cool-Coag™ technology.

Bovie Medical Corporation Reports Fourth Quarter And Full Year 2016 Results

Bovie Medical Corporation (NYSEMKT:BVX), a maker of medical devices and supplies and the developer of J-Plasma ®, a patented new surgical product, today announced financial results for the fourth quarter and full year...

Bovie Medical Corporation To Present At 29th Annual Roth Conference

Bovie Medical Corporation ("Bovie" or the "Company") (NYSE:BVX), a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, announced today that Robert L.

Bovie Medical Corporation Announces Fourth Quarter 2016 Earnings Call

Bovie Medical (BVX), a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, today announced that its fourth-quarter 2016 earnings conference call will take place at...

Bovie Medical Confirms Its 2017 Outlook

Bovie Medical Corporation (NYSE MKT:BVX) today reaffirmed its outlook for 2017.

Bovie Medical Appoints Eminent Gynecologic Oncologist To Medical Advisory Board

Bovie Medical Appoints Eminent Gynecologic Oncologist To Medical Advisory Board

Bovie Medical Corporation ("Bovie" or the "Company") (NYSE: BVX), a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, announced today the appointment of Dr.

TheStreet Quant Rating: C- (Hold)